Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line

American Journal of Chinese Medicine

Volumn 37, Issue 2, 2009, Pages 383-394

  Kuo, Kung Kai ^a   Chang, Jung San ^a,b   Wang, Kuo Chih ^a   Chiang, Lien Chai ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Enterovirus type 71; Glycyrrhiza uralensis

Indexed keywords

BETA INTERFERON; GLYCYRRHIZA URALENSIS EXTRACT; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; ENTEROVIRUS 71; HUMAN; HUMAN CELL; IC 50; INTERFERON PRODUCTION; SKIN FIBROBLAST; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS A, HUMAN; FIBROBLASTS; GLYCYRRHIZA URALENSIS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; WATER;

EID: 65449126973     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X09006904     Document Type: Article

References (32)

1. Alexander, J.P. Jr., L. Baden, M.A. Pallansch and L.J. Anderson. Enterovirus 71 infections and neurologic disease - United States, 1977-1991. J. Infect. Dis. 169: 905-908, 1994.
2. Baba, M. and S. Shigeta. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res. 7: 99-107, 1987.
3. Badam, L. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J. Commun. Dis. 29: 91-99, 1997.
4. Cardosa, M.J., S. Krishnan, P.H. Tio, D. Perera and S.C. Wong. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 354(9183): 987-991, 1999.
5. Chang, J.S., K.C. Wang and L.C. Chiang. Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fibroblast cell line. J. Ethnopharmacol. 119: 104-108, 2008.
6. Chang, L.Y., Y.C. Huang, and T.Y. Lin. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352(9125): 367-368, 1998.
7. Cheng, H.Y., T.C. Lin, C.M. Yang, K.C. Wang and C.C. Lin. Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A. Microbes. Infect. 6: 738-44, 2004.
8. Chiang, L.C., W. Chiang, M.Y. Chang, L.T. Ng and C.C. Lin. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55: 53-62, 2002.
9. Chiang, L.C., W. Chiang, S.F. Chang, H.Y. Chen and H.S. Yu. Characterization of an immortalized human cell line derived from neonatal foreskin diploid fibroblasts. J. Dermatol. 19: 1-11, 1992.
10. Chonmaitree, T., M.A. Menegus, E.M. Schervish-Swierkosz and E. Schwalenstocker. Enterovirus 71 infection: Report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics 67: 489-493, 1981.
11. Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau and H.W. Doerr. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361(9374): 2045-2046, 2003.
12. Crance, J.M., N. Scaramozzino, A. Jouan and D. Garin. Interferon, ribavirin, 6-azauridine and glycyrrhizin: Antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 58: 73-79, 2003.
13. De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 20: 323-349, 2000.
14. Fiore, C., M. Eisenhut, R. Krausse, E. Ragazzi, D. Pellati, D. Armanini and J. Bielenberg. Antiviral effects of Glycyrrhiza species. Phytother. Res. 22: 141-148, 2008.
15. Flint S.J., L.W. Enquist, V.R. Racaniello and A.M. Skalka. Principles of Virology. 2nd ed. ASM Press, Herndon, Virginia 20172, USA. 2004, pp. 165-169.
16. Harada, S. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem. J. 392: 191-199, 2005.
17. Ho, M., E.R. Chen, K.H. Hsu, S.J. Twu, K.T. Chen, S.F. Tsai, J.R. Wang and S.R. Shih. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341: 929-935, 1999.
18. Hosoya, M., Y. Kawasaki, M. Sato, K. Honzumi, A. Kato, T. Hiroshima, H. Ishiko and H. Suzuki. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr. Infect. Dis. J. 25: 691-694, 2006.
19. Hughes,W. T., D. Armstrong, G.P. Bodey, A.E. Brown, J.E. Edwards, R. Feld, P. Pizzo, K.V. Rolston, J.L. Shenep and L.S. Young. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin. Infect. Dis. 25: 551-573, 1997.
20. Kliewer, S.A. Cholesterol detoxification by the nuclear pregnane X receptor. Proc. Natl. Acad. Sci. USA 102: 2675-2676, 2005.
21. Kumada, H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 62 Suppl 1: 94-100, 2002.
22. Lange, Y., J. Ye and T.L. Steck. How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. Proc. Natl. Acad. Sci. USA 101: 11664-11667, 2004.
23. Lum, L.C., K.T. Wong, S.K. Lam, K.B. Chua and A.Y. Goh. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 352: 1391, 1998.
24. Orlent, H., B.E. Hansen, M. Willems, J.T. Brouwer, R. Huber, G.A. Kullak-Ublick, G. Gerken, S. Zeuzem, F. Nevens, W.C. Tielemans, P.E. Zondervan, M. Lagging, J.Westin and S.W. Schalm. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial. J. Hepatol. 45: 539-546, 2006.
25. Sasaki, H., M. Takei, M. Kobayashi, R.B. Pollard and F. Suzuki. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology 70: 229-236, 2002.
26. Sidwell, R.W., J.H. Huffman, G.P. Khare, L.B. Allen, J.T. Witkowski and R.K. Robins. Broadspectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177: 705-706, 1972.
27. Takei, M., M. Kobayashi, X.D. Li, R.B. Pollard and F. Suzuki. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology 72: 117-123, 2005.
28. Thyagarajan, S.P., S. Jayaram, V. Gopalakrishnan, R. Hari, P. Jeyakumar and M.S. Sripathi. Herbal medicines for liver diseases in India. J. Gastroenterol. Hepatol. 17 Suppl 3: S370-376, 2002.
29. Utsunomiya, T., M. Kobayashi, R.B. Pollard and F. Suzuki. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob. Agents Chemother. 41: 551-556, 1997.
30. Wang, J.N., C.T. Yao, C.N. Yeh, C.C. Huang, S.M. Wang, C.C. Liu and J.M. Wu. Critical management in patients with severe enterovirus 71 infection. Pediatr. Int. 48: 250-256, 2006.
31. Weislow, O.S., R. Kiser, D.L. Fine, J. Bader, R.H. Shoemaker and M.R. Boyd. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81: 577-586, 1989.
32. Yen, M.H., C.C. Lin, C.H. Chuang and S.Y. Liu. Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of "xiao-chai-hu-tang" prepared using three different Bupleurum species. J. Ethnopharmacol. 34: 155-65, 1991.